Which has grown faster, ASND or BBIO?

Over the past five years, ASND grew revenue faster — ASND at a 189.92% CAGR versus BBIO at 62.61%.

Is ASND or BBIO more profitable?

ASND runs the higher net margin — ASND at 71.08% versus BBIO at -97.64%.

Ascendis Pharma A/S (ASND) vs BridgeBio Pharma, Inc. (BBIO)

A side-by-side comparison of Ascendis Pharma A/S and BridgeBio Pharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ASND

Ascendis Pharma A/S

$14.16B

$228.03HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

BBIO

BridgeBio Pharma, Inc.

$12.95B

$66.14HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ASND vs BBIO

growth of $100 · dividends reinvested · last 7y

ASND +109.4% (+11.1%/yr)BBIO +140.1% (+13.3%/yr)BBIO compounded faster over this window

ASND BBIO

ASND vs BBIO: by the numbers

•ASND is the larger company ($14.16B vs $12.95B market cap).
•ASND is profitable (71.08% net margin) while BBIO runs a net loss (-97.64%).
•ASND grew revenue faster over the past five years (189.92% vs 62.61% CAGR).

Metrics side by side

Valuation

Metric	ASND	BBIO
P/E ratio	17.33	N/A
P/S ratio	11.59	18.17
P/B ratio	8.64	N/A
EV / EBITDA	93.79	N/A
FCF yield	2.73%	N/A

Profitability

Metric	ASND	BBIO
Gross margin	90.18%	93.35%
Operating margin	-18.92%	-113.35%
Net margin	71.08%	-97.64%
ROE	52.97%	N/A
ROIC	5.85%	-62.14%

Growth (annualized)

Metric	ASND	BBIO
Revenue CAGR (5Y)	189.92%	62.61%
Total return CAGR (5Y)	7.40%	7.38%

Frequently asked

Which has grown faster, ASND or BBIO?: Over the past five years, ASND grew revenue faster — ASND at a 189.92% CAGR versus BBIO at 62.61%.
Is ASND or BBIO more profitable?: ASND runs the higher net margin — ASND at 71.08% versus BBIO at -97.64%.

Go deeper

Full ASND analysis Full BBIO analysis Interactive comparison tool

Dig into the metrics

Ascendis Pharma A/S P/E ratio Ascendis Pharma A/S ROE BridgeBio Pharma ROE Ascendis Pharma A/S operating margin BridgeBio Pharma operating margin Ascendis Pharma A/S revenue growth BridgeBio Pharma revenue growth Ascendis Pharma A/S free cash flow BridgeBio Pharma free cash flow

Ascendis Pharma A/S & BridgeBio Pharma appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.